Literature DB >> 27065713

Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases.

Sanket S Mehta1, Maxilliano Gelli2, Deepesh Agarwal1, Diane Goéré2.   

Abstract

The combined treatment concept of cytoreductive surgery (CRS) and Hyperthermic intraperitoneal chemotherapy (HIPEC) has shown to be an efficient therapeutic option for selected patients with primary and secondary peritoneal carcinomatosis (PC). This strategy represents the standard of care for diseases like pseudomyxoma peritonei and peritoneal mesothelioma, and offers the best long-term results for PC from colorectal cancer. Despite these results, skepticism exists regarding this therapeutic approach partly because of its perceived high toxicity. In this article, we review the current evidence on complications that can occur after CRS and HIPEC and the risk factors associated with increased incidence of morbidity and mortality.

Entities:  

Keywords:  Complications; Cytoreductive Surgery; Hyperthermic intraperitoneal chemotherapy

Year:  2016        PMID： 27065713      PMCID： PMC4818615          DOI： 10.1007/s13193-016-0504-6

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


  45 in total

1.  Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures.

Authors:  O Glehen; D Osinsky; E Cotte; F Kwiatkowski; G Freyer; S Isaac; V Trillet-Lenoir; A C Sayag-Beaujard; Y François; J Vignal; F N Gilly
Journal:  Ann Surg Oncol       Date:  2003-10       Impact factor: 5.344

2.  Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion.

Authors:  Syed A Ahmad; Joseph Kim; Jeffrey J Sussman; Debbie A Soldano; Linda J Pennington; Laura E James; Andrew M Lowy
Journal:  Ann Surg Oncol       Date:  2004-04       Impact factor: 5.344

3.  A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.

Authors:  Stephanie Downs-Canner; Ying Ding; Deepa R Magge; Heather Jones; Lekshmi Ramalingam; Amer Zureikat; Matthew Holtzman; Steven Ahrendt; James Pingpank; Herbert J Zeh; David L Bartlett; Haroon A Choudry
Journal:  Ann Surg Oncol       Date:  2014-10-28       Impact factor: 5.344

4.  Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery.

Authors:  V A Lawrence; S G Hilsenbeck; C D Mulrow; R Dhanda; J Sapp; C P Page
Journal:  J Gen Intern Med       Date:  1995-12       Impact factor: 5.128

5.  Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.

Authors:  Shigeki Kusamura; Rami Younan; Dario Baratti; Pasqualina Costanzo; Myriam Favaro; Cecilia Gavazzi; Marcello Deraco
Journal:  Cancer       Date:  2006-03-01       Impact factor: 6.860

6.  Pulmonary morbidity of diaphragmatic surgery for stage III/IV ovarian cancer.

Authors:  E Chéreau; M Ballester; F Selle; A Cortez; C Pomel; E Darai; R Rouzier
Journal:  BJOG       Date:  2009-05-14       Impact factor: 6.531

7.  Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

Authors:  Dominique Elias; Jérémie H Lefevre; Julie Chevalier; Antoine Brouquet; Frédéric Marchal; Jean-Marc Classe; Gwenaël Ferron; Jean-Marc Guilloit; Pierre Meeus; Diane Goéré; Julia Bonastre
Journal:  J Clin Oncol       Date:  2008-12-22       Impact factor: 44.544

8.  Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer.

Authors:  O Glehen; V Schreiber; E Cotte; A C Sayag-Beaujard; D Osinsky; G Freyer; Y François; J Vignal; F N Gilly
Journal:  Arch Surg       Date:  2004-01

9.  Learning curve of combined modality treatment in peritoneal surface disease.

Authors:  R M Smeenk; V J Verwaal; F A N Zoetmulder
Journal:  Br J Surg       Date:  2007-11       Impact factor: 6.939

10.  Gastrointestinal complications in 147 consecutive patients with peritoneal surface malignancy treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy.

Authors:  Angela Casado-Adam; Robert Alderman; O Anthony Stuart; David Chang; Paul H Sugarbaker
Journal:  Int J Surg Oncol       Date:  2011-10-16
View more
  10 in total

Review 1.  Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey.

Authors:  M Graversen; S Detlefsen; P Pfeiffer; L Lundell; M B Mortensen
Journal:  Clin Exp Metastasis       Date:  2018-04-28       Impact factor: 5.150

Review 2.  Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies.

Authors:  David A Mahvi; Rong Liu; Mark W Grinstaff; Yolonda L Colson; Chandrajit P Raut
Journal:  CA Cancer J Clin       Date:  2018-10-17       Impact factor: 508.702

3.  Natural History and Management of Small-Bowel Obstruction in Patients After Cytoreductive Surgery and Intraperitoneal Chemotherapy.

Authors:  Eyal Mor; Shanie Shemla; Dan Assaf; Shachar Laks; Haggai Benvenisti; David Hazzan; Mai Shiber; Einat Shacham-Shmueli; Ofer Margalit; Naama Halpern; Ben Boursi; Tamar Beller; Daria Perelson; Ofer Purim; Douglas Zippel; Almog Ben-Yaacov; Aviram Nissan; Mohammad Adileh
Journal:  Ann Surg Oncol       Date:  2022-08-08       Impact factor: 4.339

Review 4.  Analgesia for Gynecologic Oncologic Surgeries: A Narrative Review.

Authors:  Kaiwal Patel; Sukhman Shergill; Nalini Vadivelu; Kanishka Rajput
Journal:  Curr Pain Headache Rep       Date:  2022-02-03

5.  Role of Imaging Studies in Evaluating Patients Post Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Mohamed Fayed; Santhalakshmi Angappan; Oghenekpaobor Oyibo; Arif Valliani
Journal:  Cureus       Date:  2021-12-22

6.  Gastric perforation following cytoreductive surgery and perioperative intraperitoneal chemotherapy: a case series of six.

Authors:  Lee S Kyang; Nayef A Alzahrani; Jing Zhao; David L Morris
Journal:  World J Surg Oncol       Date:  2017-02-10       Impact factor: 2.754

Review 7.  Review of Regional Therapies for Gastric Cancer with Peritoneal Metastases.

Authors:  Beatrice J Sun; Byrne Lee
Journal:  Cancers (Basel)       Date:  2022-01-23       Impact factor: 6.639

8.  Effect of Preoperative Immunonutrition on Postoperative Major Morbidity after Cytoreductive Surgery and HIPEC in Patients with Peritoneal Metastasis.

Authors:  Alba Fernández-Candela; Alicia Calero; Luís Sánchez-Guillén; Javier Escrig-Sos; José A Barreras; Francisco López-Rodríguez-Arias; Laura Armañanzas; Ana Murcia; Antonio Arroyo; Francisco Javier Lacueva
Journal:  Nutrients       Date:  2021-06-23       Impact factor: 5.717

Review 9.  Hyperthermic Intraperitoneal Chemotherapy in the Management of Gastric Cancer: A Narrative Review.

Authors:  Marek Mazurek; Małgorzata Szlendak; Alicja Forma; Jacek Baj; Ryszard Maciejewski; Giandomenico Roviello; Luigi Marano; Franco Roviello; Karol Polom; Robert Sitarz
Journal:  Int J Environ Res Public Health       Date:  2022-01-07       Impact factor: 3.390

10.  Cytoreductive surgery and HIPEC for malignant ascites from colorectal cancer - a randomized study.

Authors:  Mingchen Ba; Cheng Chen; Hui Long; Yuanfeng Gong; Yinbin Wu; Kunpeng Lin; Yinuo Tu; Bohuo Zhang; Wanbo Wu
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.